Loading next page...
/lp/springer_journal/response-prediction-of-altered-thyroglobulin-levels-after-radioactive-K07P0IBEb6
- Publisher
- Springer Journals
- Copyright
- Copyright © 2018 by Korean Society of Nuclear Medicine
- Subject
- Medicine & Public Health; Nuclear Medicine; Imaging / Radiology; Orthopedics; Cardiology; Oncology
- ISSN
- 1869-3474
- eISSN
- 1869-3482
- D.O.I.
- 10.1007/s13139-018-0528-7
- Publisher site
- See Article on Publisher Site
Abstract
Purpose Thyroglobulin (Tg) may be released from damaged residual thyroid tissues after radioactive iodine (RAI) therapy in patients with differentiated thyroid carcinoma (DTC). We investigated whether altered levels of serum Tg after recombinant human thyrotropin (rhTSH)-aided RAI therapy could be a prognostic marker in patients with DTC. Methods We evaluated 68 patients who underwent RAI therapy after total thyroidectomy. Serum Tg levels were measured just before RAI administration (D0Tg) and 7 days after RAI therapy (D7Tg). Patients with a D0Tg level greater than 2.0 ng/mL were excluded to more precisely evaluate the injury effect of RAI in small remnant tissues. The ratioTg was defined as the D7Tg level divided by that on D0Tg. The therapeutic responses were classified as acceptable or non-acceptable. Finally, we investigated which clinicopathologic parameters were associated with therapeutic response. Results At the follow-up examination, an acceptable response was observed in 50 patients (73.5%). Univariate analysis revealed significant differences in N stage (P = 0.003) and ratioTg (acceptable vs. non-acceptable responses, 21.9 ± 33.6 vs. 3.8 ± 6.5; P = 0.006). In multivariate analysis, only ratioTg significantly predicted an acceptable response (odds ratio 1.104; 95% confidence interval 1.005–1.213; P = 0.040). A ratioTg above 3.5 predicted
Journal
Nuclear Medicine and Molecular Imaging – Springer Journals
Published: Jun 4, 2018
@Phil_Robichaud
@deepthiw
@JoseServera